ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Chai Discovery raised $400 million in a Series C round led by Index Ventures, valuing the San Francisco startup at $3.8 billion. The company uses generative AI to design antibodies and proteins from scratch. Its models are deployed at Eli Lilly, Pfizer, and Novartis.
Tap to vote and see what everyone thinks.
Summary by ByteBrief